Physician profile
Robert Johnson
NPI 1053308825
$2,198.95
in general payments reported to CMS, 2019-2025
7 companies · $41.00 in 2025
The $41.00 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $31.95 · 2021: $14.96 · 2023: $1,221 · 2024: $890 · 2025: $41.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,776 · Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,776.26 |
| Food and Beverage | $375.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $1,255.04 | 2023-2024 | Aria Radiation Therapy Management Software, Truebeam, Varian Ethos Treatment Planning |
| Accuray Incorporated | $823.08 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $34.29 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $33.66 | 2020-2023 | Xarelto |
| Boston Scientific Corporation | $18.96 | 2023 | Spaceoar Vue System - 10ml |
| Varian Medical Systems, INC. | $18.96 | 2020 | |
| Janssen Biotech, INC. | $14.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.